Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin Immunotherapy-Reference-Cited by-同舟云学术

Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin Immunotherapy

Published:1990-07 Issue:1 Volume:144 Page:59-64
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Böhle A.¹²,Nowc Ch.¹²,Ulmer A.J.¹²,Musehold J.¹²,Gerdes J.¹²,Hofstetter A.G.¹²,Flad H.-D.¹²

Affiliation:

1. From the Department of Urology, Medical University of Lübeck, Lübeck

2. Department of Immunology and Cell Biology, Borstel Research Institute, Borstel, Federal Republic of Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference39 articles.

1. Experience with bacillus Calmette-Guerin in patients with superficial bladder cancer;Brosman;J. Urol.,1982

2. The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ;Brosman;J. Urol.,1985

3. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer;Catalona;J. Urol.,1987

4. Effect of intravesical bacillus CalmetteGuerin on carcinoma in situ of the bladder;Herr;Cancer,1983

5. An overview of intravesical therapy for superficial bladder tumors;Herr;J. Urol.,1987

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy options for painful bladder syndrome: what’s the potential?;Expert Opinion on Biological Therapy;2017-09-05

2. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists;Cancer Research;2017-03-14

3. Mise au point sur le traitement d’entretien par bacille de Calmette-Guérin en 2015;Progrès en Urologie - FMC;2015-12

4. Terapia de inducción bacillus Calmette-Guérin: en búsqueda del esquema ideal;Revista Mexicana de Urología;2015-11

5. Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013;European Urology;2015-08